Get the full North Immunology company profile
Access contacts, investors, buying signals & more
North Immunology has raised $180.0M to push forward a class of bispecific antibodies aimed at inflammatory and immune diseases.
The privately held biotech's lead program, NOR-101, is a half-life extended anti-IL-13 x IL-18 bispecific antibody designed to inhibit both the type 2 and non-type 2 inflammation that drives atopic dermatitis. The company's broader goal is to develop therapies that could offer best-in-disease efficacy, safety, and patient convenience.
🧬Another Austin healthtech unicorn, a $180M biotech financing, and real-time speech from an implanted BCI lead this week’s Austin Bio & Health Roundup.
🧬 💰 Funding & Capital Thatch raised a $108M Series C at a $1B valuation after revenue grew nearly 7x in a year, and moved into a new Austin office that is now its largest. North Immunology agreed to merge with Aethlon Medical alongside a $180M private placement. The combined company will operate as North Immunology and trade as NRTX. 🚀 Launches & Milestones Paradromics’ first long-term Conne
Slayd
Creating a Gen Z-focused fashion discovery platform by leveraging their social media-driven inspiration and browsing habits.
$156.0K Pre-seed
today
Embra AI
Embra is building the data network powering Physical AI. We connect real-world robotics data with the teams building the next generation of intelligent machines. Our platform brings together dataset discovery, evaluation, curation and sourcing across multimodal data including video, sensor measurements, robot state and actions. From manipulation and object handovers to navigation and other real-world tasks, we help robotics teams find and assess data relevant to the environments, machines and capabilities they are developing. For robotics teams looking for training data, or contributors with relevant datasets, visit embra.network.
$1.0M Pre-seed
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Plora.ai Hungary | Unknown | $1.4M | today |
| 2 |  Joiin United Kingdom | Unknown | $1.7M | today |
Plora.ai
Plora.ai | 193 followers on LinkedIn.
$1.4M Unknown
today
| $7.2B |
| 2y ago |
| 3 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 4 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 8mo ago |
| 3 |
 ProducePay United States |
| Unknown |
| $140.0M |
| today |
| 4 |  Watu Brazil | Unknown | $7.0M | today |
| 5 |  Vheda Health United States | Unknown | $47.0M | today |
Trusted by 200+ sales teams
See who invested in North Immunology and reach their contacts directly.
Start free trial
Induvita AS
Recently received
PHOSPHOENIX
Recently received
AbTx
Recently received
